ebook Munafa Stock Market Course + Intraday & FNO calls  

       

532523 announcements Biocon Ltd. announcements and dividends declared BSE

Biocon Ltd. Complete list of announcements declared & dividend announcements by Biocon Ltd. 532523

Biocon Ltd. 532523 listed on BSE and deals in

Announcements and dividends declared by Biocon Ltd. 532523

Liraglutide still a ‘decent market’ despite Novo’s price moves: Siddharth Mittal, Biocon
Biocon CEO Siddharth Mittal outlines the company's strategy in the competitive GLP-1 market. Focusing on liraglutide's launch in the US and Europe, he highlights opportunities in emerging markets. While semaglutide is a longer-term play, Biocon is active
Announcement as on 26 February 2026

Biocon Q3FY26 results: Revenue up 9%, net profit rises on generics push
Board gives in-principle nod to make Biocon Biologics a wholly owned subsidiary as Q3 net profit climbs to Rs 143.8 crore
Announcement as on 12 February 2026

S&P Global upgrades Biocon Biologics ratings
S&P Global Ratings on Wednesday upgraded Biocon Biologics ratings with a stable outlook.
Announcement as on 28 January 2026

Biocon QIP to ease balance sheet pressure; metals, PSU banks favoured in near term: Nischal Maheshwari
Biocon's fundraising is viewed positively to manage debt. Expert Nischal Maheshwari is optimistic about Biocon's future, expecting earlier investments to yield returns. He also favors contract development and manufacturing firms like Laurus Labs. Maheshwar
Announcement as on 13 January 2026

Biocon arm gets USFDA nod for generic Everolimus tablets
Biocon's arm, Biocon Pharma Ltd, has secured USFDA approval for its generic Everolimus tablets. This medication aids in treating tuberous sclerosis complex, a rare genetic disorder causing tumors. The approval for 2mg, 3mg, and 5mg strengths bolsters Bioco
Announcement as on 12 January 2026

Announcements by Biocon Ltd. first page | Next page | Prev page |

532523 Biocon Ltd. current price & indicator signals

Moving Averages for Biocon Ltd.

  • 5Day Average: 342.91
  • 12Day Average: 341.47
  • 20Day Average: 351.86
  • 50Day Average: 381.28
  • 100Day Average: 401.98
  • 150Day Average: 395.04
  • 200Day Average: 391.14

532523 Indicators & signals

Indicator MACD (12,26,9)

346.18, 357.96, -14.19
Indicator MACD is in negative zone

Indicator ADX (14)

15.14, 23.79, 32.29
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 45
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 532523 Biocon Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 352.00 348.60 to 355.20 0% 0.5 times
29 Thu Oct 2026 352.00 349.50 to 357.25 0.57% 0.82 times
28 Wed Oct 2026 350.00 330.85 to 350.00 4.85% 0.82 times
27 Tue Oct 2026 333.80 328.40 to 334.60 2.16% 0.4 times
26 Mon Oct 2026 326.75 321.65 to 329.75 0.05% 0.67 times
23 Fri Oct 2026 326.60 318.50 to 331.15 -0.96% 0.69 times
22 Thu Oct 2026 329.75 328.50 to 335.90 -1.12% 0.43 times
21 Wed Oct 2026 333.50 331.00 to 343.85 -2.06% 1.13 times
19 Mon Oct 2026 340.50 340.10 to 349.35 -2.71% 0.77 times
16 Fri Oct 2026 350.00 348.10 to 352.95 -0.43% 3.84 times
15 Thu Oct 2026 351.50 350.25 to 356.05 0.07% 0.44 times
14 Wed Oct 2026 351.25 346.95 to 352.80 0.06% 1.03 times

Videos related to: 532523 announcements Biocon Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

532523 announcements Biocon Ltd. announcements and dividends declared BSE

 

Back to top